The Solubility of an active drug molecule is the quantity of a drug (solute) that can be dissolved in a particular solution (solvent) at a fixed temperature and pressure to generate a saturated solution. It is a fundamental quality that must be assessed throughout the early phases of drug research. Active drug solubility analysis is the technique of calculating the dissolution curve of a molecule in a given volume of solvent, which is useful for gaining a basic knowledge of the medicine's pharmacodynamic qualities. As a result, Solubility Analysis is critical in the creation of medication formulations. A solution is a homogenous combination of one or more solutes in a solvent. Sugar cubes in a cup of tea or coffee are a popular example of a solution. Solubility refers to the quality that allows sugar molecules to dissolve. As a result, the term solubility may be defined as the ability of a material (solute) to dissolve in a specific solvent. A solute is any material that dissolves in a solvent and might be solid, liquid, or gas. Solubility analysis is the technique of determining the dissolution profile of a chemical in a given volume of solvent. The determination of Drug Material Solubility has a substantial impact on bio/pharmaceutical development and is beneficial for a preliminary knowledge of the pharmacodynamic features.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico